Multimodal Fusion: A Review of Breast Cancer Advanced and Traditional Modalities

Multimodal fusion combines traditional and emerging breast imaging techniques with AI to enhance cancer detection, but challenges like data diversity and interpretability must be addressed.

Multimodal Fusion: A Review of Breast Cancer Advanced and Traditional Modalities

Introduction

Breast cancer detection relies on a suite of imaging tools, each highlighting different tissue characteristics. While mammography, ultrasound, and magnetic resonance imaging (MRI) remain clinical staples, newer modalities—thermal, photoacoustic, microwave, and multimodal microscopy—offer complementary insights. The recent surge in artificial intelligence (AI) enables these diverse data sources to be fused at the raw data, feature, and decision levels, promising more accurate diagnosis, better tumor characterization, and personalized treatment planning.

Traditional Modalities and Their Strengths

  • Mammography provides high‑resolution, low‑cost structural images, excelling at detecting micro‑calcifications and mass margins. Its widespread availability makes it the primary screening tool.
  • Ultrasound adds real‑time, radiation‑free imaging, useful for differentiating cystic from solid lesions and guiding biopsies, especially in dense breast tissue where mammography sensitivity drops.
  • MRI offers superior soft‑tissue contrast and functional information through dynamic contrast‑enhanced sequences, aiding in assessing tumor extent, multifocal disease, and response to therapy.

These techniques are often used together; for example, a suspicious mammographic finding may be further evaluated with ultrasound or MRI to refine the diagnosis.

Emerging Modalities Expanding the Diagnostic Palette

  • Thermal Imaging captures surface temperature variations linked to metabolic activity, potentially flagging malignancies that exhibit increased heat.
  • Photoacoustic Imaging merges optical contrast with ultrasonic resolution, revealing vascular patterns and oxygenation levels within tumors.
  • Microwave Imaging exploits dielectric property differences between healthy and cancerous tissue, offering a non‑ionizing alternative for dense breasts.
  • Multimodal Microscopy integrates fluorescence, reflectance, and scattering signals at the cellular level, supporting histopathological assessment without excision.

These newer approaches provide functional and molecular cues that traditional structural imaging cannot capture, making them attractive candidates for fusion.

AI‑Driven Fusion Strategies

AI models now operate at three fusion tiers:

  1. Data‑Level Fusion – raw pixel or signal data from multiple modalities are combined, often using deep convolutional networks that learn joint representations.
  2. Feature‑Level Fusion – handcrafted or learned features (e.g., texture, shape, vascular metrics) are merged before classification, allowing the model to weigh modality‑specific contributions.
  3. Decision‑Level Fusion – independent modality classifiers produce predictions that are aggregated via voting, stacking, or Bayesian methods.

Applications span detection, lesion classification, segmentation, prognosis, and treatment response prediction. Moreover, integrating imaging with clinical records, histopathology, and genomic profiles creates a truly multimodal patient view, supporting precision oncology.

Remaining Challenges and Future Directions

  • Dataset Diversity – Large, annotated multimodal datasets are scarce, limiting model generalizability across populations and scanner variations.
  • Protocol Standardization – Inconsistent acquisition settings hinder seamless fusion; community‑wide standards are needed.
  • Missing Modalities – Real‑world scans often lack one or more modalities; robust algorithms must handle incomplete inputs gracefully.
  • External Validation – Few studies have demonstrated performance across multiple centers, a prerequisite for clinical adoption.
  • Interpretability & Trust – Clinicians require transparent AI decisions; explainable models and visual attribution maps are essential.
  • Privacy & Security – Fusion of imaging with genomic data raises privacy concerns; techniques like federated learning and differential privacy can mitigate risks.

Future research should prioritize building diverse, multi‑institutional repositories, developing adaptable fusion frameworks, and rigorously validating models in prospective clinical trials. Emphasizing explainability and privacy will help bridge the gap between promising algorithms and routine breast cancer care.

Conclusion

Multimodal fusion stands at the intersection of advanced imaging and AI, offering a pathway to more accurate and comprehensive breast cancer detection. By thoughtfully combining structural, functional, and molecular information—and addressing current data, validation, and interpretability hurdles—the field can move toward reliable, patient‑centered diagnostics that improve outcomes and streamline clinical workflows.

Source

Read original source

Why we picked this

Medical imaging review involving multimodal AI techniques.

← Back to all articles